Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

103 (48%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2023-11-03 2024-01-19 209145
TEVA-BUDESONIDE 0.5MG SUSPENSION Actual shortage 2023-06-19 2025-05-02 195478
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2021-12-17 2022-02-05 151448
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2021-04-29 2021-08-07 138291
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2021-06-03 2021-10-14 140390
TEVA-BUDESONIDE 0.125MG SUSPENSION Actual shortage 2024-08-08 2025-04-24 234891
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2023-06-20 2023-07-06 195815
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2020-04-02 2020-06-04 110679
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2020-01-09 2020-03-05 102923
TEVA-BUDESONIDE 0.5MG SUSPENSION Resolved 2022-05-19 2022-06-09 160994
TEVA-BUDESONIDE 0.125MG SUSPENSION Resolved 2020-03-06 2020-03-19 107964
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2024-03-07 2024-06-27 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-06-07 223856

Showing 861 to 880 of 2930

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Discontinued 2025-10-22 2025-10-22 257579
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173

Showing 61 to 80 of 300